Aeries Technology, Inc. - Quarter Report: 2023 March (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
98-1587626 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
F13-16 |
||
OREM, |
84097 | |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant |
WWACU | The Nasdaq Stock Market | ||
Class A ordinary shares, par value $0.0001 per share |
WWAC | The Nasdaq Stock Market | ||
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
WWACW | The Nasdaq Stock Market | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
WORLDWIDE WEBB ACQUISITION CORP.
FORM 10-Q TABLE OF
CONTENTS
Table of Contents
March 31, 2023 |
December 31, 2022 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Cash |
$ | 11,751 | $ | 48,126 | ||||
Prepaid expenses |
264,738 | 304,314 | ||||||
Other current assets |
5,835 | 8,334 | ||||||
|
|
|
|
|||||
Total current assets |
282,324 | 360,774 | ||||||
Marketable securities held in Trust Account |
237,085,266 | 234,716,046 | ||||||
|
|
|
|
|||||
Total Assets |
$ |
237,367,590 |
$ |
235,076,820 |
||||
|
|
|
|
|||||
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 5,643,831 | $ | 676,652 | ||||
Promissory note - related party |
431,692 | 200,000 | ||||||
Accrued professional services fees |
408,708 | 3,091,220 | ||||||
Accrued expenses |
62,267 | 42,267 | ||||||
|
|
|
|
|||||
Total current liabilities |
6,546,498 | 4,010,139 | ||||||
Derivative warrant liabilities |
2,244,000 | 614,040 | ||||||
Deferred legal fees |
— | 343,437 | ||||||
|
|
|
|
|||||
Total liabilities |
8,790,498 | 4,967,616 | ||||||
|
|
|
|
|||||
Commitments and Contingencies (Note 5) |
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 shares at $10.30 and 10.20 per share at March 31, 2023 and December 31, 2022, respectively |
236,985,266 | 234,616,046 | ||||||
|
|
|
|
|
|
|
|
|
Shareholders’ deficit |
||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued or outstanding (excluding 23,000,000 shares subject to possible redemption) |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding |
575 | 575 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(8,408,749 | ) | (4,507,417 | ) | ||||
|
|
|
|
|||||
Total shareholders’ deficit |
(8,408,174 | ) | (4,506,842 | ) | ||||
|
|
|
|
|||||
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
$ |
237,367,590 |
$ |
235,076,820 |
||||
|
|
|
|
For The Three Months Ended March 31, 2023 |
For The Three Months Ended March 31, 2022 |
|||||||
General and administrative expenses |
$ | 2,271,372 | $ | 362,637 | ||||
|
|
|
|
|||||
Loss from operations |
(2,271,372 |
) |
(362,637 |
) | ||||
Change in fair value of derivative warrant liabilities |
(1,629,960 | ) | 4,082,040 | |||||
Gain on marketable securities, dividends and interest, held in Trust Account |
2,369,220 | 80,352 | ||||||
|
|
|
|
|
|
|
|
|
Net (loss) income |
$ |
(1,532,112 |
) |
$ |
3,799,755 |
|||
|
|
|
|
|||||
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted |
23,000,000 | 23,000,000 | ||||||
|
|
|
|
|||||
Basic and diluted net (loss) income per share, Class A ordinary shares subject to possible redemption |
$ |
(0.05 |
) |
$ |
0.13 |
|||
|
|
|
|
|||||
Weighted average shares outstanding of Class B non-redeemable ordinary shares, basic and diluted |
5,750,000 | 5,750,000 | ||||||
|
|
|
|
|||||
Basic and diluted net (loss) income per share, Class B non-redeemable ordinary shares |
$ |
(0.05 |
) |
$ |
0.13 |
|||
|
|
|
|
Temporary Equity |
Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance as of January 1, 2023 |
23,000,000 | $ | 234,616,046 | 5,750,000 | $ | 575 | $ | — | $ | (4,507,417 | ) | $ | (4,506,842 | ) | ||||||||||||||
Remeasurement of Class A ordinary shares to redemption value |
— | 2,369,220 | — | — | — | (2,369,220 | ) | (2,369,220 | ) | |||||||||||||||||||
Net loss |
— | — | — | — | — | (1,532,112 | ) | (1,532,112 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2023 (unaudited) |
23,000,000 |
$ |
236,985,266 |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(8,408,749 |
) |
$ |
(8,408,174 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
FOR THE THREE MONTHS ENDED MARCH 31, 2022 (Unaudited) |
| |||||||||||||||||||||||||||
Temporary Equity |
Ordinary Shares |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||||||||||
Class A |
Class B |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance as of January 1, 2022 |
23,000,000 | $ | 232,300,000 | 5,750,000 | $ | 575 | $ | — | $ | (19,798,626 | ) | $ | (19,798,051 | ) | ||||||||||||||
Net income |
— | — | — | — | — | 3,799,755 | 3,799,755 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2022 (unaudited) |
23,000,000 |
$ |
232,300,000 |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(15,998,871 |
) |
$ |
(15,998,296 |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Three Months Ended March 31, 2023 |
For The Three Months Ended March 31, 2022 |
|||||||
Cash Flows from Operating Activities |
||||||||
Net (loss) income |
$ | (1,532,112 | ) | $ | 3,799,755 | |||
Adjustments to reconcile net (loss) income to net cash used in operating activities: |
||||||||
Gain on marketable securities, dividends and interest, held in Trust Account |
(2,369,220 | ) | (80,352 | ) | ||||
Formation and operating expenses funded by note payable through Sponsor |
71,692 | 14,101 | ||||||
Change in fair value of derivative warrant liabilities |
1,629,960 | (4,082,040 | ) | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid and other assets |
42,075 | 53,656 | ||||||
Accounts payable |
4,967,179 | — | ||||||
Accrued expenses |
(2,662,512 | ) | 66,684 | |||||
|
|
|
|
|||||
Net cash provided (used) in operating activities |
147,062 | (228,196 | ) | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from note payable and advances from related party |
160,000 | — | ||||||
Deferred legal fees paid |
(343,437 | ) | (20,000 | ) | ||||
|
|
|
|
|||||
Net cash used in financing activities |
(183,437 | ) | (20,000 | ) | ||||
|
|
|
|
|||||
Net decrease in cash |
(36,375 | ) | (248,196 | ) | ||||
Cash - beginning of period |
48,126 | 503,204 | ||||||
|
|
|
|
|||||
Cash - end of period |
$ |
11,751 |
$ |
255,008 |
||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Remeasurement of Class A shares to redemption value |
2,369,220 | — | ||||||
|
|
|
|
Gross proceeds |
$ | 230,000,000 | ||
Less: |
|
|
| |
Class A ordinary shares issuance costs |
(21,834,402 | ) | ||
Fair value of Public Warrants at issuance |
(5,784,500 | ) | ||
Plus: |
| |||
Remeasurement of Class A ordinary shares to redemption value |
32,234,948 | |||
|
|
|
|
|
Class A ordinary shares subject to possible redemption at December 31, 2022 |
$ | 234,616,046 | ||
Remeasurement of Class A ordinary shares to redemption value |
2,369,220 | |||
|
|
|||
Class A ordinary shares subject to possible redemption at March 31, 2023 |
$ | 236,985,266 | ||
|
|
For The Three Months Ended March 31, 2023 |
For The Three Months Ended March 31, 2022 |
|||||||
Redeemable Class A Ordinary Shares |
||||||||
Numerator: Net (loss) income allocable to Redeemable Class A Ordinary Shares |
$ | (1,225,690 | ) | $ | 3,039,804 | |||
Denominator: Weighted Average Share Outstanding, Redeemable Class A Ordinary Shares |
23,000,000 | 23,000,000 | ||||||
|
|
|
|
|||||
Basic and diluted net (loss) income per share, Class A ordinary shares subject to possible redemptions |
$ |
(0.05 |
) |
$ |
0.13 |
|||
|
|
|
|
|||||
Non-Redeemable Class B Ordinary Shares |
||||||||
Numerator: Net (loss) income allocable to non-redeemable Class B Ordinary Shares |
$ | (306,422 | ) | $ | 759,951 | |||
Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares |
5,750,000 | 5,750,000 | ||||||
|
|
|
|
|||||
Basic and diluted net (loss) income per share, Class B non-redeemable ordinary shares |
$ |
(0.05 |
) |
$ |
0.13 |
|||
|
|
|
|
• | 30 days after the completion of th e Initial Business Combination or, |
• | 12 months from the closing of the Initial Public Offering; |
• | In whole and not in part; |
• | At a price of $0.01 per Warrant; |
• | Upon a minimum of 30 days’ prior written notice of redemption, referred to as the 30-day redemption period; and |
• | if, and only if, the last sale price of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, dividends, reorganization, recapitalizations, and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at a price of $0.10 per Warrant, provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of Class A ordinary shares determined in part by the redemption date and the “fair market value” of the Class A ordinary shares except as otherwise below; |
• | upon a minimum of 30 days’ prior written notice of redemption; and |
• | if, and only if, the last sale price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations, and the like) on the trading day prior to the date on which we send the notice of redemption to the warrant holders. |
Description | Level | Fair Value | ||||||||
March 31, 2023 |
Marketable securities | 1 | $ | 237,085,266 | ||||||
December 31, 2022 |
Marketable securities | 1 | $ | 234,716,046 |
March 31, 2023 | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Liabilities: |
||||||||||||||||
|
$ | 1,265,000 | $ | — | $ | — | $ | 1,265,000 | ||||||||
Private Placement Warrants |
— | 979,000 | — | 979,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
$ | 1,265,000 | $ | 979,000 | $ | — | $ | 2,244,000 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
December 31, 2022 | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Liabilities: |
||||||||||||||||
|
$ | 346,150 | $ | — | $ | — | $ | 346,150 | ||||||||
Private Placement Warrants |
— | 267,890 | — | 267,890 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
$ | 346,150 | $ | 267,890 | $ | — | $ | 614,040 | ||||||||
|
|
|
|
|
|
|
|
Public Warrant Liability |
Private Warrant Liability |
Total | ||||||||||
Fair value at January 1, 2023 |
$ | 346,150 | $ | 267,890 | $ | 614,040 | ||||||
|
(918,850 | ) | (711,110 | ) | (1,629,960 | ) | ||||||
|
|
|
|
|
|
|||||||
Fair value as of March 31, 2023 |
$ | 1,265,000 | $ | 979,000 | $ | 2,244,000 | ||||||
|
|
|
|
|
|
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this annual report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Overview
We are a newly incorporated blank check company, incorporated on March 5, 2021, as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. We have not selected any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our IPO and the sale of the private placement warrants, our shares, debt or a combination of cash, shares and debt.
The issuance of additional ordinary shares or preference shares in a business combination:
• | may significantly dilute the equity interest of investors in our IPO, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
• | may subordinate the rights of holders of ordinary shares if preference shares are issued with rights senior to those afforded our ordinary shares; |
• | could cause a change of control if a substantial number of our ordinary shares is issued, which result in the resignation or removal of our present directors and officers; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, ordinary shares and/or warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
Similarly, if we issue debt or otherwise incur significant indebtedness, it could result in:
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our ordinary shares, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
18
Table of Contents
Results of Operations and Known Trends or Future Events
We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for our IPO. Following our IPO, we will not generate any operating revenues until after completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents after our IPO. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. After our IPO, we expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. We expect our expenses to increase substantially after the closing of our IPO.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception through March 31, 2023 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, our the Company’s search for a target business with which to complete a Business Combination and activities in connection with the proposed Transactions. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We generate non-operating income in the form of interest income on marketable securities. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination.
For the three months ended March 31, 2023, we had a net loss of $1,532,112, which consists of general and administrative expenses of $2,271,372 and a loss from the change in fair value of derivative warrant liabilities of $1,629,960, offset by an unrealized gain on marketable securities held in the Trust Account of $2,369,220.
For the three months ended March 31, 2022, we had net income of $3,799,755, which consists of general and administrative expenses of $362,637, offset by and a gain from the change in fair value of derivative warrant liabilities of $4,082,040 and by an unrealized gain on marketable securities held in the Trust Account of $80,352.
Liquidity, Capital Resources and Going Concern Considerations
Until the consummation of the Initial Public Offering, the Company’s only source of liquidity was an initial purchase of ordinary shares by the Sponsor and loans from our Sponsor.
On October 22, 2021, we consummated the Initial Public Offering of 20,000,000 shares, at a price of $10.00 per Unit, generating gross proceeds of $200,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 8,000,000 Private Placement Warrants to the Sponsor at a price of $1.00 per warrant, generating gross proceeds of $8,000,000. On November 15, 2021, the underwriters exercised their overallotment option to purchase 3,000,000 ordinary shares and 1,500,000 public warrants, at a price of $10.00 per Unit, generating gross proceeds of $30,000,000. Also on November 15, 2021, we consummated additional sale of 900,000 Private Placement Warrants to the Sponsor at a price of $1.00 per warrant, generating gross proceeds of $900,000.
Following the Initial Public Offering and the sale of the Private Placement Warrants, a total of $232,300,000 was placed in the Trust Account. We incurred $21,834,402 in transaction costs, including $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees and $9,184,402 of other costs.
For the three months ended March 31, 2023, cash provided in operating activities was $147,062. The net loss of $(1,532,112) was offset by general and administrative expenses paid by related party of $71,692, interest earned on investment held in Trust Account of $2,369,220, changes in fair value of derivative warrant liabilities of $1,629,960, and changes in operating assets and liabilities, which generated $2,346,742 of cash.
As of March 31, 2023, we had cash of $11,751. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.
As of March 31, 2023, we had cash and marketable securities held in the Trust Account of $237,085,266. We may withdraw interest to pay our income taxes, if any. We intend to use substantially all the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of taxes payable and excluding deferred underwriting commissions) to complete our Business Combination. To the extent that our share capital is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
19
Table of Contents
In order to fund working capital needs or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant unit at the option of the lender. The warrants would be identical to the Private Placement Warrants.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
Going Concern Considerations
On a routine basis, we assess going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 205-40 “Presentation of Financial Statements — Going Concern”. As of March 31, 2023, we had $11,751 in our operating bank account, a working capital deficit of $6,264,174, and $237,085,266 of securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem our ordinary shares in connection therewith. In connection with our assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” we have determined that mandatory liquidation and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. We believe that we may not have sufficient working capital and borrowing capacity to meet our needs through the earlier of the consummation of a business combination or one year from this filing. However, there is a risk that our liquidity may not be sufficient. The Sponsor intends, but is not obligated to, provide us with Working Capital Loans to sustain operations in the event of a liquidity deficiency.
We have until October 22, 2023 to consummate a Business Combination. If a Business Combination is not consummated by this date and an extension is not requested by the Sponsor there will be a mandatory liquidation and subsequent dissolution of the Company. Uncertainty related to consummation of a Business Combination raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after October 22, 2023. The financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities to reflect a required liquidation after October 22, 2023.
20
Table of Contents
Related Party Transactions
In March 2021, our sponsor subscribed for an aggregate of 8,625,000 Class B ordinary shares, par value $0.0001 per share, for an aggregate purchase price of $25,000. On September 17, 2021, our sponsor effected a surrender of 2,875,000 Class B ordinary shares to us the company for no consideration, resulting in a decrease in the number of Class B ordinary shares outstanding from 8,625,000 to 5,750,000, such that the total number of founder shares would represent 20% of the total number of ordinary shares outstanding upon completion of our IPO.
We have entered into an Administrative Services Agreement pursuant to which we pay our sponsor a total of $10,000 per month for office space, utilities, secretarial, administrative and support services, up to a maximum of $160,000. The maximum threshold of $160,000 was reached in February 2023, so we will cease paying these monthly fees in the following months.
Our sponsor, directors and officers, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, directors, officers or our or any of their respective affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.
In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our directors and officers may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants issued to our sponsor. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
Our sponsor purchased an aggregate of 8,900,000 private placement warrants at a price of $1.00 per warrant ($8,900,000 in the aggregate) in a private placement that occurred simultaneously with the closing of our IPO. Each private placement warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as provided herein. The private placement warrants are identical to the warrants sold as part of the units in our IPO except that, so long as they are held by our sponsor or its permitted transferees: (1) they will not be redeemable by us (except under certain circumstances when the price per Class A ordinary share equals or exceeds $10.00); (2) they (including the Class A ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by our sponsor until 30 days after the completion of our initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the ordinary shares issuable upon exercise of these warrants) are entitled to registration rights.
Pursuant to a registration rights agreement entered into with our initial shareholders and anchor investors, we may be required to register certain securities for sale under the Securities Act. These holders, and holders of warrants issued upon conversion of working capital loans, if any, are entitled under the registration rights agreement to make up to three demands that we register certain of our securities held by them for sale under the Securities Act and to have the securities covered thereby registered for resale pursuant to Rule 415 under the Securities Act. In addition, these holders have the right to include their securities in other registration statements filed by us. However, the registration rights agreement provides that we will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions, as described herein. We will bear the costs and expenses of filing any such registration statements. See “Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters—Registration Rights.”
Off-Balance Sheet Arrangements; Commitments and Contractual Obligations; Quarterly Results
As of March 31, 2023, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations. No unaudited quarterly operating data is included in this report as we have conducted no operations to date.
21
Table of Contents
JOBS Act
On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things: (1) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act; (2) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd- Frank Wall Street Reform and Consumer Protection Act; (3) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis); and (4) disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As of March 31, 2023, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in certain U.S. government obligations with a maturity of 185 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2023, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded that, as of the evaluation date, our disclosure controls and procedures were effective as of March 31, 2023.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control Over Financial Reporting
Other than the remediation discussed below, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Background and Remediation of Material Weakness - Technical Accounting Related to Accruals
Management previously identified a material weakness in our internal control over financial reporting related to the recording of an accrual, as disclosed in “Part II, Item 9A. Controls and Procedures” in our Annual Report and as described further below. A material weakness is defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
The material weakness related specifically to a duplication of legal fees accrual, which led to an overstatement of accrued expenses and general and administrative expenses. Our controls, specifically the review of assumptions and understanding the nuance of these recording accruals, did not operate as designed, resulting in an adjustment in the second quarter of 2022 to reduce the balances for accrued expenses and general and administrative expenses within the financial statements. Management has determined that the material weakness was remediated during the three months ended March 31, 2023, due to enhancements made to our business processes and related internal controls during the period. The Company also ensured that the relevant staff identify and appropriately apply applicable accounting requirements to better evaluate and understand the processes of recording accruals, including providing enhanced access to accounting literature, research materials, and increased communication among the Company’s personnel and third-party professionals with whom management consults.
PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
None.
ITEM 1A. RISK FACTORS.
In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risks discussed in our annual report on Form 10-K filed with the SEC on March 31, 2023. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially adversely affect our business, financial condition, or future results. There have been no material changes in the risk factors discussed in our annual report.
22
Table of Contents
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5. OTHER INFORMATION.
None.
ITEM 6. EXHIBITS
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
23
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
WORLDWIDE WEBB ACQUISITION CORP. | ||||
Date: May 22, 2023 | /s/ Daniel S. Webb | |||
Name: | Daniel S. Webb | |||
Title: | Chief Executive Officer and Chief Financial Officer |
24